GCC Genetic Counseling Market

ID: MRFR/LS/50614-HCR
200 Pages
Vikita Thakur
Last Updated: April 06, 2026
GCC Genetic Counseling Market Research Report: By Counseling Approach (Integrated, Independent, Discretionary Genetic Counseling), By Key Players Business Model (Core Genetic Counseling Companies, Direct-to-Consumer Genetic Testing Companies, Clinical Genetic Testing Companies), By Channel (Providers, Self-Referred Individuals), By Type of Service (Risk Assessment, Pharmacogenomics, Other Genetic Pediatric Care Counseling Services), By Application (Proactive Risk Assessment, GC For Intent-to-Treat Patients (ITT), Prenatal and Preconception Care, Other), By Target Population Segment (General Population, Patient Population) andBy Level of Service (Pre-counseling Support, Post Counseling Support) - Growth & Industry Forecast 2025 To 2035
GCC Genetic Counseling Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)14.5%
2024 Market Size$ 34.35 Million
2025 Market Size$ 39.33 Million
2035 Market Size$ 152.36 Million
Key Players
Myriad Genetics
Invitae Corporation
Ambry Genetics
GeneDx
Fulgent Genetics
23andMe
Trends
  • Increased Demand for Genetic Testing
  • Integration of Genetic Counseling in Healthcare Systems
  • Focus on Preventive Healthcare
Opportunities
  • Government Initiatives and Support
  • Rising Awareness of Genetic Disorders
  • Increasing Prevalence of Chronic Diseases
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Counseling Approach (USD Million)
      1. 4.1.1 Integrated
      2. 4.1.2 Independent
      3. 4.1.3 Discretionary Genetic Counseling
    2. 4.2 Healthcare, BY Key Players Business Model (USD Million)
      1. 4.2.1 Core Genetic Counseling Companies
      2. 4.2.2 Direct-to-Consumer Genetic Testing Companies
      3. 4.2.3 Clinical Genetic Testing Companies
    3. 4.3 Healthcare, BY Channel (USD Million)
      1. 4.3.1 Providers
      2. 4.3.2 Self-Referred Individuals
    4. 4.4 Healthcare, BY Type of Service (USD Million)
      1. 4.4.1 Risk Assessment
      2. 4.4.2 Pharmacogenomics
      3. 4.4.3 Other Genetic Pediatric Care Counseling Services
    5. 4.5 Healthcare, BY Application (USD Million)
      1. 4.5.1 Proactive Risk Assessment
      2. 4.5.2 GC For Intent-to-Treat Patients (ITT)
      3. 4.5.3 Prenatal and Preconception Care
      4. 4.5.4 Others
    6. 4.6 Healthcare, BY Target Population Segment (USD Million)
      1. 4.6.1 General Population
      2. 4.6.2 Patient Population
    7. 4.7 Healthcare, BY Level of Service (USD Million)
      1. 4.7.1 Pre-counseling Support
      2. 4.7.2 Post Counseling Support
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Myriad Genetics (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Invitae Corporation (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Ambry Genetics (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 GeneDx (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Fulgent Genetics (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 23andMe (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Color Genomics (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Natera (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 GCC MARKET ANALYSIS BY COUNSELING APPROACH
    3. 6.3 GCC MARKET ANALYSIS BY KEY PLAYERS BUSINESS MODEL
    4. 6.4 GCC MARKET ANALYSIS BY CHANNEL
    5. 6.5 GCC MARKET ANALYSIS BY TYPE OF SERVICE
    6. 6.6 GCC MARKET ANALYSIS BY APPLICATION
    7. 6.7 GCC MARKET ANALYSIS BY TARGET POPULATION SEGMENT
    8. 6.8 GCC MARKET ANALYSIS BY LEVEL OF SERVICE
    9. 6.9 KEY BUYING CRITERIA OF HEALTHCARE
    10. 6.10 RESEARCH PROCESS OF MRFR
    11. 6.11 DRO ANALYSIS OF HEALTHCARE
    12. 6.12 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    13. 6.13 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    14. 6.14 SUPPLY / VALUE CHAIN: HEALTHCARE
    15. 6.15 HEALTHCARE, BY COUNSELING APPROACH, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY COUNSELING APPROACH, 2024 TO 2035 (USD Million)
    17. 6.17 HEALTHCARE, BY KEY PLAYERS BUSINESS MODEL, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY KEY PLAYERS BUSINESS MODEL, 2024 TO 2035 (USD Million)
    19. 6.19 HEALTHCARE, BY CHANNEL, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY CHANNEL, 2024 TO 2035 (USD Million)
    21. 6.21 HEALTHCARE, BY TYPE OF SERVICE, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY TYPE OF SERVICE, 2024 TO 2035 (USD Million)
    23. 6.23 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    24. 6.24 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    25. 6.25 HEALTHCARE, BY TARGET POPULATION SEGMENT, 2024 (% SHARE)
    26. 6.26 HEALTHCARE, BY TARGET POPULATION SEGMENT, 2024 TO 2035 (USD Million)
    27. 6.27 HEALTHCARE, BY LEVEL OF SERVICE, 2024 (% SHARE)
    28. 6.28 HEALTHCARE, BY LEVEL OF SERVICE, 2024 TO 2035 (USD Million)
    29. 6.29 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY COUNSELING APPROACH, 2025-2035 (USD Million)
      2. 7.2.2 BY KEY PLAYERS BUSINESS MODEL, 2025-2035 (USD Million)
      3. 7.2.3 BY CHANNEL, 2025-2035 (USD Million)
      4. 7.2.4 BY TYPE OF SERVICE, 2025-2035 (USD Million)
      5. 7.2.5 BY APPLICATION, 2025-2035 (USD Million)
      6. 7.2.6 BY TARGET POPULATION SEGMENT, 2025-2035 (USD Million)
      7. 7.2.7 BY LEVEL OF SERVICE, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

GCC Genetic Counseling Market Segmentation

GCC Genetic Counseling Market By Counseling Approach (USD Million, 2025-2035)

  • Integrated
  • Independent
  • Discretionary Genetic Counseling

GCC Genetic Counseling Market By Key Players Business Model (USD Million, 2025-2035)

  • Core Genetic Counseling Companies
  • Direct-to-Consumer Genetic Testing Companies
  • Clinical Genetic Testing Companies

GCC Genetic Counseling Market By Channel (USD Million, 2025-2035)

  • Providers
  • Self-Referred Individuals

GCC Genetic Counseling Market By Type of GCC Genetic Counseling Market (USD Million, 2025-2035)

  • Risk Assessment
  • Pharmacogenomics
  • Other Genetic Pediatric Care Counseling GCC Genetic Counseling Markets

GCC Genetic Counseling Market By Application (USD Million, 2025-2035)

  • Proactive Risk Assessment
  • GC For Intent-to-Treat Patients (ITT)
  • Prenatal and Preconception Care
  • Others

GCC Genetic Counseling Market By Target Population Segment (USD Million, 2025-2035)

  • General Population
  • Patient Population

GCC Genetic Counseling Market By Level of GCC Genetic Counseling Market (USD Million, 2025-2035)

  • Pre-counseling Support
  • Post Counseling Support

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.